Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Samsung SDI (006400) – Kyobo Securities | AI Data Center BBU · Direct CSP Channels · 1Q Earnings Beat / 2026-04-29 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | AI Infrastructure · LTA · HBM Demand / 2026-06-09 Research
  • [Research] Samsung Electro-Mechanics (009150) – iM Securities | Silicon Capacitor LTA · Fabless Model · SOTP Re-rating / 2026-05-21 Research
  • [Research] LIG D&A (079550) – Hana Securities | Complementing Patriot · Cheongung-II Cost Competitiveness · KRW 26.2T Backlog / 2026-03-03 Research
  • [Research] LigaChem Biosciences (141080) – Mirae Asset Securities | Clinical Milestones · Commercialization Potential · Platform PoC / 2025-05-23 Research
  • [Research] Samsung Electro-Mechanics (009150) – DS Investment & Securities | MLCC Price Leverage · Capacity Cannibalization · Earnings Upward Revisions / 2026-07-31 Research
  • [Research] Samsung SDI (006400) – Hana Securities | SDC Stake Monetization Pursuit · Up to KRW 11T Liquidity · Valuation Multiples Re-rating / 2026-02-20 Research
  • [Research] Hanwha Ocean (042660) – iM Securities | Merchant Profit Surprise · Special Ship Sentiment · Valuation De-rating / 2026-07-28 Research

Author: ksb220805@gmail.com

[Research] ABL Bio (298380) – Mirae Asset Securities | BBB Shuttle Re-rating · IGF1R Competitiveness · ABL001 Data Readout / 2026-03-26

Posted on March 26, 2026August 21, 2026 By ksb220805@gmail.com
[Research] ABL Bio (298380) – Mirae Asset Securities | BBB Shuttle Re-rating · IGF1R Competitiveness · ABL001 Data Readout / 2026-03-26

Brokerage : Mirae Asset Securities Analyst : Seungmin Kim Investment Rating : Not Rated Target Price : – Core Momentum : Re-rating of the IGF1R-targeting Grabody-B platform following Denali’s initial BBB shuttle FDA approval, alongside upcoming ABL001 Phase 2/3 trial data readout in April 📊 1. [Valuation & Key Financial Metrics] 🚀 2. [Market Opportunities…

Read More “[Research] ABL Bio (298380) – Mirae Asset Securities | BBB Shuttle Re-rating · IGF1R Competitiveness · ABL001 Data Readout / 2026-03-26” »

Research, Bio & Healthcare

[Research] SK hynix (000660 / SKHY) – Mirae Asset | ADR Listing · Valuation Gap · Re-rating / 2026-03-25

Posted on March 25, 2026August 24, 2026 By ksb220805@gmail.com
[Research] SK hynix (000660 / SKHY) – Mirae Asset | ADR Listing · Valuation Gap · Re-rating / 2026-03-25

Market: KOSPI (000660) Brokerage : Mirae Asset Securities Analyst : Younggun Kim, Dahyun Jang Investment Rating : BUY (Maintained) Target Price : 1,540,000 KRW (Maintained) Core Momentum : The U.S. ADR listing process is expected to establish a new global valuation benchmark and narrow the multiple discount to overseas memory peers, while robust earnings growth…

Read More “[Research] SK hynix (000660 / SKHY) – Mirae Asset | ADR Listing · Valuation Gap · Re-rating / 2026-03-25” »

Research, Semiconductors

[Research] LigaChem Biosciences (141080) – Shinhan Securities | ConjuALL · Clinical Milestones · Big Pharma L/O / 2026-03-24

Posted on March 24, 2026August 21, 2026 By ksb220805@gmail.com
[Research] LigaChem Biosciences (141080) – Shinhan Securities | ConjuALL · Clinical Milestones · Big Pharma L/O / 2026-03-24

Brokerage : Shinhan Securities Analyst : Hocheol Lee, Minyong Eom Investment Rating : Not Rated Target Price : – Core Momentum : Acceleration into a large-scale licensing phase supported by upcoming 1H clinical readouts for LCB71 and LCB84 alongside clinical track records with global big pharma 📊 1. [Valuation & Key Financial Metrics] 🚀 2….

Read More “[Research] LigaChem Biosciences (141080) – Shinhan Securities | ConjuALL · Clinical Milestones · Big Pharma L/O / 2026-03-24” »

Research, Bio & Healthcare

[Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · ADR Listing · Valuation Re-rating / 2026-03-23

Posted on March 23, 2026August 24, 2026 By ksb220805@gmail.com
[Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · ADR Listing · Valuation Re-rating / 2026-03-23

Market: KOSPI (000660) Brokerage : Mirae Asset Securities Analyst : Younggun Kim Investment Rating : BUY (Maintained) Target Price : 1,540,000 KRW (Maintained) Core Momentum : Resilient memory pricing and structural capacity constraints are driving upward earnings revisions, while the planned U.S. ADR listing provides a potential catalyst for multiple expansion and valuation re-rating. 📊…

Read More “[Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · ADR Listing · Valuation Re-rating / 2026-03-23” »

Research, Semiconductors

[Research] Samsung SDI (006400) – Mirae Asset Securities | BBU Momentum · Hungarian Utilization Rebound · 2026 Operating Profit Turnaround / 2026-03-18

Posted on March 18, 2026August 22, 2026 By ksb220805@gmail.com
[Research] Samsung SDI (006400) – Mirae Asset Securities | BBU Momentum · Hungarian Utilization Rebound · 2026 Operating Profit Turnaround / 2026-03-18

Brokerage : Mirae Asset Securities Analyst : Chul-joong Kim Investment Rating : BUY (Maintained) Target Price : KRW 600,000 (Maintained) Core Momentum : Driven by accelerated demand for high-margin cylindrical BBUs in ESS and plant utilization recovery in Hungary, the company is projected to turn an operating profit in 2026 alongside strong North American ESS…

Read More “[Research] Samsung SDI (006400) – Mirae Asset Securities | BBU Momentum · Hungarian Utilization Rebound · 2026 Operating Profit Turnaround / 2026-03-18” »

Research, EV & Battery

[Research] SK hynix (000660 / SKHY) – Daishin | Memory ASP · Earnings Upgrades · Valuation Appeal / 2026-03-16

Posted on March 16, 2026August 24, 2026 By ksb220805@gmail.com
[Research] SK hynix (000660 / SKHY) – Daishin | Memory ASP · Earnings Upgrades · Valuation Appeal / 2026-03-16

Market: KOSPI (000660) Brokerage : Daishin Securities Analyst : Hyungkeun Ryu, RA Jiwon Seo Investment Rating : BUY (Maintained) Target Price : 1,450,000 KRW (Maintained) Core Momentum : Sharp DRAM and NAND ASP increases are expected to drive a significant Q1 earnings beat and substantial full-year earnings upgrades, while the recent share-price correction leaves valuation…

Read More “[Research] SK hynix (000660 / SKHY) – Daishin | Memory ASP · Earnings Upgrades · Valuation Appeal / 2026-03-16” »

Research, Semiconductors

[Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · Supply Deficit · Valuation Appeal / 2026-03-04

Posted on March 4, 2026August 24, 2026 By ksb220805@gmail.com
[Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · Supply Deficit · Valuation Appeal / 2026-03-04

Market: KOSPI (000660) Brokerage : Mirae Asset Securities Analyst : Younggun Kim Investment Rating : BUY (Maintained) Target Price : 1,540,000 KRW (Maintained) Core Momentum : Resilient memory pricing and a widening gap between limited capacity expansion and demand growth indicate that underlying fundamentals remain intact, while the geopolitically driven share-price correction has created significant…

Read More “[Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · Supply Deficit · Valuation Appeal / 2026-03-04” »

Research, Semiconductors

[Research] LIG D&A (079550) – Hana Securities | Complementing Patriot · Cheongung-II Cost Competitiveness · KRW 26.2T Backlog / 2026-03-03

Posted on March 3, 2026August 21, 2026 By ksb220805@gmail.com
[Research] LIG D&A (079550) – Hana Securities | Complementing Patriot · Cheongung-II Cost Competitiveness · KRW 26.2T Backlog / 2026-03-03

Brokerage : Hana Securities Analyst : Woonsam Chae Investment Rating : BUY (Maintain) Target Price : KRW 710,000 (Upward) Core Momentum : Severe supply bottlenecks and high costs for US Patriot systems driving global demand for Cheongung-II, supported by a KRW 26.2T order backlog anchoring multi-year earnings compounding through 2028 1. [Valuation & Key Financial…

Read More “[Research] LIG D&A (079550) – Hana Securities | Complementing Patriot · Cheongung-II Cost Competitiveness · KRW 26.2T Backlog / 2026-03-03” »

Research, Defense

[Research] SK hynix (000660 / SKHY) – Kiwoom | Legacy Memory Pricing · Earnings Upgrades · Volume Growth / 2026-03-03

Posted on March 3, 2026August 24, 2026 By ksb220805@gmail.com
[Research] SK hynix (000660 / SKHY) – Kiwoom | Legacy Memory Pricing · Earnings Upgrades · Volume Growth / 2026-03-03

Market: KOSPI (000660) Brokerage : Kiwoom Securities Analyst : Yuak Pak Investment Rating : BUY (Maintain) Target Price : 1,300,000 KRW (Upgraded) Core Momentum : Sharp legacy DRAM and NAND price increases are driving substantial earnings upgrades, while the memory cycle is expected to transition from price-led gains toward CapEx-supported volume growth as profitability strengthens….

Read More “[Research] SK hynix (000660 / SKHY) – Kiwoom | Legacy Memory Pricing · Earnings Upgrades · Volume Growth / 2026-03-03” »

Research, Semiconductors

[Research] SK hynix (000660 / SKHY) – SK Securities | AI Memory · NAND Tiering · Earnings Re-rating / 2026-02-24

Posted on February 24, 2026August 24, 2026 By ksb220805@gmail.com
[Research] SK hynix (000660 / SKHY) – SK Securities | AI Memory · NAND Tiering · Earnings Re-rating / 2026-02-24

Market: KOSPI (000660) Brokerage : SK Securities Analyst : Donghee Han Investment Rating : BUY (Maintained) Target Price : 1,600,000 KRW (Upgraded) Core Momentum : AI memory demand is expanding beyond HBM into DRAM and NAND, with inference-driven memory tiering creating a new role for NAND while multi-dimensional supply constraints strengthen pricing power, earnings visibility,…

Read More “[Research] SK hynix (000660 / SKHY) – SK Securities | AI Memory · NAND Tiering · Earnings Re-rating / 2026-02-24” »

Research, Semiconductors

Posts pagination

Previous 1 … 21 22 23 … 31 Next
  • [Research] LIG D&A (079550) – Kiwoom Securities | Order Visibility · Production Expansion · Middle East Deliveries / 2026-08-07 Research
  • [Research] Samsung Electro-Mechanics (009150) – Shinhan Securities | High-Value Order Expansion · ASP Growth · Earnings Upward Revision / 2026-07-31 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | Long-term Exclusive Contracts · 2029 Target EPS · Structural ASP Hikes / 2026-06-01 Research
  • [Research] LIG D&A (079550) – Hana Securities | 4Q25 Miss · Solid Order Backlog · Medium-to-Long-term Fundamentals / 2026-02-19 Research
  • [Research] LIG D&A (079550) – Yuanta Securities | Cheongung-II Demand Surge · OPM Guidance Upgrade · Middle East Overlap / 2026-08-07 Research
  • [Research] Samsung Biologics (207940) – IBK Securities | US Operations · Plant 5 Ramp-up · Peptide Expansion / 2026-07-24 Research
  • [Research] Hanwha Ocean (042660) – Eugene | High-Price Order Mix · Merchant Margin Continuity · Special Ship Pipeline / 2026-07-28 Research
  • [Research] Samsung SDI (006400) – Hana Securities | Stepwise Loss Reduction · Strong ESS BBU Shipments · 4Q26 Turnaround / 2026-02-03 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme